Metabolic Dysfunction Associated Steatohepatitis Treatment Market is Expected to Expand at a CAGR of 21.8% from 2024 to 2031 - Madrigal Pharmaceuticals, Simson Pharma Limited, Dr. Reddy's Laboratories Ltd.

The Global Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment Market reached US$ 1.67 billion in 2023 and is expected to reach US$ 7.64 billion by 2031, growing at a CAGR of 21.8% during the forecast period 2024-2031.

Metabolic Dysfunction Associated Steatohepatitis Treatment Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/metabolic-dysfunction-associated-steatohepatitis-treatment-market?rk

Metabolic Dysfunction-Associated Steatohepatitis (MASH) treatment focuses on managing liver inflammation and fat accumulation caused by metabolic disorders like obesity and diabetes. Current approaches include lifestyle modifications such as diet and exercise, medications targeting insulin resistance and liver fibrosis, and emerging therapies like FXR agonists and GLP-1 receptor agonists. Clinical trials are evaluating novel drugs to reduce liver damage and prevent disease progression. Early diagnosis and intervention are crucial to avoiding complications like cirrhosis and liver failure.

List of the Key Players in the Metabolic Dysfunction Associated Steatohepatitis Treatment Market:

Madrigal Pharmaceuticals, Simson Pharma Limited, Dr. Reddy's Laboratories Ltd., Thermo Fisher Scientific Inc., Biosynth, Affgility Solutions, Conscientia Industrial Co. Ltd., Smolecule Inc., 89 Bio Inc., and Sandoo Pharmaceuticals and Chemicals Co. Ltd.

Industry Development:

In August 2024, Altimmune reported that its experimental therapy, pemvidutide, significantly reduced liver fat, inflammation, and body weight in overweight or obese individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) during Phase I clinical trials. A Phase 2b trial, known as IMPACT (NCT05989711), is currently testing pemvidutide against a placebo in up to 190 adults with metabolic dysfunction-associated steatohepatitis (MASH).

In July 2024, researchers from Northwestern Polytechnical University and Air Force Medical University published a study indicating that phytic acid-based nanomedicine shows promise for treating MASH due to cerium's antioxidant, anti-inflammatory properties, and hepatophilicity.

Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=metabolic-dysfunction-associated-steatohepatitis-treatment-market?rk

Growth Forecast Projected:

The Global Metabolic Dysfunction Associated Steatohepatitis Treatment Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Metabolic Dysfunction Associated Steatohepatitis Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/metabolic-dysfunction-associated-steatohepatitis-treatment-market?rk

Segment Covered in the Metabolic Dysfunction Associated Steatohepatitis Treatment Market:

By Treatment: Drug, Therapy, Weight Management, Diabetes control, Regular Exercise, Foscarnet, Others

By End-User: Hospitals, Specialty Clinics, Homecare, Others

Regional Analysis for Metabolic Dysfunction Associated Steatohepatitis Treatment Market:

The regional analysis of the Metabolic Dysfunction Associated Steatohepatitis Treatment Market covers key regions including North America, Europe, Asia Pacific Middle East and Africa and South America. The North America with a focus on the U.S., Canada, and Mexico; Europe, highlighting major countries like the U.K., Germany, France, and Italy, along with other nations in the region; Asia-Pacific, covering India, China, Japan, South Korea, and Australia, among others; South America, with emphasis on Colombia, Brazil, and Argentina; and the Middle East & Africa, which includes Saudi Arabia, the U.A.E., South Africa, and other countries. This comprehensive regional breakdown helps identify unique market trends and growth opportunities specific to each area.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/metabolic-dysfunction-associated-steatohepatitis-treatment-market?rk

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Metabolic Dysfunction Associated Steatohepatitis Treatment market?

➠ Who are the leading manufacturers in the global Metabolic Dysfunction Associated Steatohepatitis Treatment industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Metabolic Dysfunction Associated Steatohepatitis Treatment industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Metabolic Dysfunction Associated Steatohepatitis Treatment market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Browse More Reports: https://www.datamintelligence.com/research-report/metabolic-dysfunction-associated-steatohepatitis-treatment-market?rk

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.